FinTrust Capital Advisors’s Avanos Medical AVNS Stock Holding History

FinTrust Capital Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$529	Hold	22	–	–	﹤0.01%	1310
2024 Q2	$439	Buy	22 +12	+120%	+$234	﹤0.01%	1316
2024 Q1	$200	Sell	10 -3	-23%	-$58	﹤0.01%	1235
2023 Q4	$292	Hold	13	–	–	﹤0.01%	1208
2023 Q3	$263	Buy	13 +8	+160%	+$181	﹤0.01%	1190
2023 Q2	$136	Hold	5	–	–	﹤0.01%	1175
2023 Q1	$136	Hold	5	–	–	﹤0.01%	1164
2022 Q4	$135	Hold	5	–	–	﹤0.01%	1162
2022 Q3	$0	Hold	5	–	–	﹤0.01%	1219
2022 Q2	$0	Hold	5	–	–	﹤0.01%	1211
2022 Q1	$0	Hold	5	–	–	﹤0.01%	1216
2021 Q4	$0	Hold	5	–	–	﹤0.01%	1185
2021 Q3	$0	Sell	5 -6	-55%	-$204	﹤0.01%	1155
2021 Q2	$0	Hold	11	–	–	﹤0.01%	1163
2021 Q1	$0	Hold	11	–	–	﹤0.01%	1137
2020 Q4	$1K	Hold	11	–	–	﹤0.01%	1037
2020 Q3	$0	Hold	11	–	–	﹤0.01%	1135
2020 Q2	$0	Hold	11	–	–	﹤0.01%	1057
2020 Q1	$0	Hold	11	–	–	﹤0.01%	1105
2019 Q4	$0	Hold	11	–	–	﹤0.01%	1065
2019 Q3	$0	Hold	11	–	–	﹤0.01%	1052
2019 Q2	$0	Sell	11 -100	-90%	-$4.28K	﹤0.01%	1055
2019 Q1	$5K	Sell	111 -9	-8%	-$403	﹤0.01%	918
2018 Q4	$5K	Buy	+120	New	+$6.29K	﹤0.01%	912

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

FinTrust Capital Advisors's AVNS Position: Q3 2024 in Review

FinTrust Capital Advisors held its Avanos Medical (AVNS) position steady in Q3 2024 at 22 shares worth $529. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

FinTrust Capital Advisors first reported a position in AVNS in Q4 2018 and has held it in 24 quarters since. The position peaked at $5K in Q1 2019. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2024.

FinTrust Capital Advisors held 22 shares of Avanos Medical worth $529 as of Q3 2024.
FinTrust Capital Advisors left its Avanos Medical share count unchanged in Q3 2024.
Avanos Medical made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1310 holding.
FinTrust Capital Advisors first reported a position in Avanos Medical in Q4 2018 and has held it in 24 quarters since.
FinTrust Capital Advisors's Avanos Medical position peaked at $5K in Q1 2019.
260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.